These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2725439)

  • 1. Protection afforded by clonidine from the acute and chronic behavioral toxicity produced by the cholinesterase inhibitor soman.
    Buccafusco JJ; Graham JH; VanLingen J; Aronstam RS
    Neurotoxicol Teratol; 1989; 11(1):39-44. PubMed ID: 2725439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of alpha 2-adrenergic receptor stimulation in reducing the central toxicity following cholinesterase inhibition.
    Buccafusco JJ; Li W
    Res Commun Chem Pathol Pharmacol; 1992 Jan; 75(1):85-98. PubMed ID: 1352646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral effects of toxic doses of soman, an organophosphate cholinesterase inhibitor, in the rat: protection afforded by clonidine.
    Buccafusco JJ; Graham JH; Aronstam RS
    Pharmacol Biochem Behav; 1988 Feb; 29(2):309-13. PubMed ID: 3362926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse.
    Buccafusco JJ; Aronstam RS
    J Pharmacol Exp Ther; 1986 Oct; 239(1):43-7. PubMed ID: 3761196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term behavioral and learning abnormalities produced by the irreversible cholinesterase inhibitor soman: effect of a standard pretreatment regimen and clonidine.
    Buccafusco JJ; Heithold DL; Chon SH
    Toxicol Lett; 1990 Aug; 52(3):319-29. PubMed ID: 2389260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of central biogenic amines on the protection afforded by clonidine against the toxicity of soman, an irreversible cholinesterase inhibitor.
    Buccafusco JJ; Aronstam RS; Graham JH
    Toxicol Lett; 1988 Sep; 42(3):291-9. PubMed ID: 3176058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonidine protection from soman and echothiophate toxicity in mice.
    Aronstam RS; Smith MD; Buccafusco JJ
    Life Sci; 1986 Dec; 39(22):2097-102. PubMed ID: 3784771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection by clonidine from the cardiovascular changes and lethality following soman administration in the rat: role of brain acetylcholine.
    Magrí V; Buccafusco JJ; Aronstam RS
    Toxicol Appl Pharmacol; 1988 Sep; 95(3):464-73. PubMed ID: 3188010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenergic agonists protect against soman, an irreversible acetylcholinesterase inhibitor.
    Buccafusco JJ; Aronstam RS
    Toxicol Lett; 1987 Sep; 38(1-2):67-76. PubMed ID: 2820088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone- and dose schedule-dependent protection by HI-6 against soman and tabun poisoning.
    Lundy PM; Goulet JC; Hand BT
    Fundam Appl Toxicol; 1989 Apr; 12(3):595-603. PubMed ID: 2659414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology.
    McDonough JH; Jaax NK; Crowley RA; Mays MZ; Modrow HE
    Fundam Appl Toxicol; 1989 Aug; 13(2):256-76. PubMed ID: 2792594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo protection against soman toxicity by known inhibitors of acetylcholine synthesis in vitro.
    Sterling GH; Doukas PH; Sheldon RJ; O'Neill JJ
    Biochem Pharmacol; 1988 Feb; 37(3):379-84. PubMed ID: 3337738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subchronic physostigmine pretreatment in marmosets: absence of side effects and effectiveness against soman poisoning with negligible postintoxication incapacitation.
    Philippens IH; Vanwersch RA; Groen B; Olivier B; Bruijnzeel PL; Melchers BP
    Toxicol Sci; 2000 Jan; 53(1):84-91. PubMed ID: 10653525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of endogenous carboxylesterase on HI-6 protection against soman toxicity.
    Maxwell DM; Koplovitz I
    J Pharmacol Exp Ther; 1990 Aug; 254(2):440-4. PubMed ID: 2384881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diet composition modifies the toxicity of repeated soman exposure in rats.
    Langston JL; Myers TM
    Neurotoxicology; 2011 Dec; 32(6):907-15. PubMed ID: 21641933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
    Cho Y; Kim WS; Hur GH; Ha YC
    Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual behavioral incapacitation after therapy of soman intoxication: the effect of a soman simulator.
    Wolthuis OL; Vanwersch RA; Van Helden HP
    Neurobehav Toxicol Teratol; 1986; 8(2):127-30. PubMed ID: 3713961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration and intensity of behavioral change after sublethal exposure to soman in rats.
    Haggerty GC; Kurtz PJ; Armstrong RD
    Neurobehav Toxicol Teratol; 1986; 8(6):695-702. PubMed ID: 3808185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions.
    Blick DW; Miller SA; Brown GC; Murphy MR
    Pharmacol Biochem Behav; 1993 Jul; 45(3):677-83. PubMed ID: 8332626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxication.
    Shih TM; McDonough JH
    Arch Toxicol; 2000 May; 74(3):165-72. PubMed ID: 10877003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.